Related Experiment Video
Updated: Sep 26, 2026

Assessment of Morphine-induced Hyperalgesia and Analgesic Tolerance in Mice Using Thermal and Mechanical Nociceptive Modalities
Published on: July 29, 2014
The clinically available NMDA receptor antagonist dextromethorphan attenuates acute morphine withdrawal in the
Hongbo Zhu1, Shirzad Jenab, Kathy L Jones
1Department of Pharmacology, Weill Medical College of Cornell University, LC-524, 1300 York Ave., New York, NY 10021, USA. hoz2004@med.cornell.edu
Abstract:
We investigated the ability of dextromethorphan, a clinically available NMDA receptor antagonist, to attenuate the behaviors and the expression of c-fos mRNA associated with acute morphine withdrawal in the 7-day-old rat. The intensity of the acute morphine withdrawal behaviors and the elevation in c-fos mRNA expression in the brain induced by acute morphine withdrawal were reduced by dextromethorphan. Thus, dextromethorphan can attenuate acute morphine withdrawal in the developing organism.
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Opioid Analgesics: Morphine and Other Natural Cogeners
Analgesia and Pain Management
Opioid Receptors: Overview
Parenteral Anesthetics: Overview
CNS Depressants: Alcohol and Nicotine

